Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer's disease models.
- Open access
- 5 cites
Deletion of SPI1 in microglia worsens amyloid pathology by reducing microglial response and phagocytosis in Alzheimer's disease models.
- Why it matters: Understanding microglial gene functions is crucial because they influence the development and progression of Alzheimer's disease, yet their specific roles remain unclear.
- What they did: Researchers used genetic deletion of Spi1 in microglia within an amyloid mouse model, analyzing effects on amyloid deposition, gliosis, neurites, and microglial activity through proteomics and functional assays.
- The result: Loss of Spi1 increased amyloid accumulation and impaired microglial phagocytosis, but activating related genes restored amyloid-beta uptake, highlighting SPI1's role in modulating amyloid pathology.